ShangRing
DeviceShangRing device for male circumcision
NCT Number: NCT02242565
The purpose of this study was to assess the safety, effectiveness and acceptability of providing a reduced number of ShangRing sizes for adult voluntary medical male circumcision (VMMC) within routine service delivery in Lusaka, Zambia.
Looking for future studies?
Notify Me18 year–49 year
Male
Interventional
Not applicable
Chilenje Urban Health Centre, Lusaka, Zambia
We conducted a randomized controlled trial and enrolled 500 HIV-negative men aged 18-49 years at 3 clinics. Participants were randomized to 1 of 2 study arms (Standard Sizing arm vs Modified Sizing arm) in a 1:1 ratio. All 14 adult ShangRing sizes (40-26 mm inner diameter, each varying by 1 mm) were available in the Standard Sizing arm; the Modified Sizing arm used every other size (40, 38, 36, 34, 32, 30, 28 mm inner diameter). Each participant was scheduled for 2 follow-up visits: the removal visit (day 7 after placement) and the healing check visit (day 42 after placement), when they were evaluated for adverse events (AEs), pain, and healing.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ShangRing device for male circumcision
Time frame: 42 days
To assess the safety of ShangRing procedures when providers choose among 7 adult sizes (reduced-sizes or treatment arm) versus the full range of 14 adult sizes (all-sizes or control arm) during routine service delivery in Lusaka, Zambia.
Time frame: 42 days
Assess the effectiveness of ShangRing procedures in the reduced-sizes arm.
Time frame: 42 days
Participant acceptability (with procedure and cosmetic appearance), pain, and time to return to normal activity after ShangRing circumcision, overall and in each arm.
Provider acceptability assessing ease, duration, and complications, and preferences comparing ShangRing with other methods of circumcision, and comparing reduced-sizes with all-sizes provision.
Time frame: Day 42
Percentage of men with complete healing at 42 days for all study participants, and within each arm of the trial.
FHI 360
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07094555
Anxiety Disorders, Male Circumcision
Merkez, Kars, Turkey (Türkiye)
View Trial DetailsNCT04263064
Male Circumcision
Charleston, South Carolina, United States
View Trial DetailsNCT03223532
Male Circumcision
Kisumu, Nyanza, Kenya
View Trial DetailsNCT02091726
Male Circumcision
Cape Town, Western Cape, South Africa
View Trial Details